
Loading, please wait...

Loading, please wait...

Researchers at Spain's University of Granada have developed a fish scale artificial cornea. This innovative medical device utilizes scales from several common fish species found in local markets. Consequently, it provides a promising, lower-cost alternative to traditional donor transplants for patients with severe eye diseases.
The cornea is the eye's transparent front layer. However, it is remarkably difficult to repair when badly damaged because it lacks blood vessels and has limited regenerative capacity. Doctors often treat severe corneal conditions with donor transplants. Unfortunately, these procedures are frequently limited by organ availability and long waiting lists.
Scientists from the university's Tissue Engineering Group created these corneal implants to be highly biocompatible, transparent, and resistant. Furthermore, this biological product is very accessible and inexpensive to obtain. It could also help boost the local fishing industry by utilizing byproducts. Testing suggests the material is highly useful for corneal repair and tissue regeneration. Nevertheless, the technology remains far from clinical use in humans until human trials are complete.
The research team reported good functional results in both laboratory studies and animal models. Although standard transplants usually offer good results, we must develop new effective regeneration methods. These methods should not depend solely on organ donation. A 2016 peer-reviewed paper from Antwerp University also confirmed that fish-scale-derived corneas were compatible with human tissues. Therefore, this innovation marks a significant step forward in regenerative medicine.
Q1: Why are fish scales used for artificial corneas?
Fish scales are naturally transparent, durable, and highly biocompatible. They provide a cost-effective scaffold that mimics the protein structure of the human cornea.
Q2: When will this treatment be available for patients?
While laboratory and animal trials are successful, human clinical trials must be completed before the treatment is approved for general medical use.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Spanish researchers develop a low-cost artificial cornea from fish scales, offering a biocompatible alternative to donor transplants for severe eye diseases...
5 months ago

A comprehensive analysis of continuous glucose monitoring systems under European Medical Device Regulation 2017/745, examining conformity assessment challenges, Notified Body backlogs, EUDAMED rollout delays, and the critical need for transparent post-market surveillance.
Today

A multicenter MPOG database study of 289,047 cesarean delivery cases analyzed adherence to obstetric anesthesia best practices. General anesthesia avoidance reached 97.0%, while post-spinal vasopressor infusions (55.4%) and hypothermia prevention (56.7%) showed the lowest compliance, highlighting key targets.
Yesterday

A comprehensive meta-analysis shows digital health technologies significantly improve 6-minute walk distance and peak oxygen uptake in chronic heart failure patients, highlighting the clinical promise of structured remote cardiac rehabilitation.
Today

Recent research assesses an automated pipeline for CT-based vertebral finite element analysis, revealing how boundary condition components—especially load-point assignment—impact fracture-load accuracy in spinal biomechanics.
Today

The Supreme Court of India has sharply criticized the Food Safety and Standards Authority of India for delaying front-of-package warning labels. With non-communicable diseases causing over 6 million deaths annually, clear nutritional warnings are critical to combat childhood obesity, diabetes, and cardiovascular risk.
Today